Article
The impact of p53 protein core domain structural alteration on ovarian cancer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2003
Rose Stephen L, Robertson Andrew D, Goodheart Michael J, Smith Brian J, DeYoung Barry R, Buller Richard E
Abstract excerpt
PURPOSE: Although survival with a p53 missense mutation is highly variable, p53-null mutation is an independent adverse prognostic factor for advanced stage ovarian cancer. By evaluating ovarian cancer survival based upon a structure function analysis of the p53 protein, we tested the hypothesis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
